Independent dataset verification indicated that CD3D, GZMK, and KLRB1 can well distinguish RA patients from normal and osteoarthritis (OA) patients and has high sensitivity and specificity for ACPA-negative RA patients. The gene discussed is GZMK; the disease is rheumatoid arthritis.